Literature DB >> 10475152

Growth hormone bioactivity and immunoactivity in tall children.

M Bozzola1, G Radetti, F Buzi, G Tonini, A Moretta, M Autelli, A Aglialoro, G Rondini, A Barreca.   

Abstract

In subjects with constitutional tall stature, both low and high GH response to stimulation tests have been observed when measured by commercial kits. To investigate the reason for these conflicting results, we evaluated growth hormone (GH) secretion using different assays as well as GH-binding protein and insulin-like growth factor-I (IGF-I) concentrations in tall children. Serum samples were collected from 22 prepubertal constitutionally tall children, aged 2.87-13.25 years, during two pharmacological tests to evaluate serum GH levels measured by both immunofluorometric assay (IFMA) and the Nb2 cell bioassay. Serum IGF-I values were evaluated by RIA. Circulating low affinity (LA) and high affinity (HA) GH-binding proteins (GHBPs) were evaluated by FPLC gel filtration. Considering the highest serum GH levels as measured by IFMA, the 22 tall subjects were divided into two groups: group A including 16 children with blunted serum GH peak levels (5.78+/-0.68 ng/ml) and group B including 6 subjects with normal serum GH peak values (15.73+/-1.56 ng/ml). No differences were observed in serum GH peak levels as measured by the Nb2 cell bioassay between group A (14.77+/-1.54 ng/ml) and group B (16.03+/-1.96 ng/ml), and between both groups and 11 age-and sex-matched controls (12.25+/-1.19 ng/ml). In group A, the Nb2 cell bioassay/IFMA ratio of serum GH peak levels (0.29+/-0.08) was significantly higher (p<0.05) than in group B (0.07+/-0.01). No differences were found in serum LA-GHBP and HA-GHBP as well as in IGF-I concentrations between the 16 patients of group A and the 6 of group B. Likewise, no difference in auxological parameters was found between the two groups. The biological activity of GH evaluated using the Nb2 cell bioassay is similar in tall children with a low GH response as measured by IFMA in comparison with those with a normal GH response, and is in agreement with both the auxological data and serum IGF-I concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475152     DOI: 10.1007/BF03343606

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

Review 1.  Receptor assays for growth hormone.

Authors:  H G Friesen
Journal:  Acta Paediatr Scand Suppl       Date:  1990

Review 2.  Growth hormone binding proteins and various forms of growth hormone: implications for measurements.

Authors:  G Baumann
Journal:  Acta Paediatr Scand Suppl       Date:  1990

Review 3.  Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins.

Authors:  G Baumann
Journal:  Endocr Rev       Date:  1991-11       Impact factor: 19.871

4.  [Study of tall stature in children. Low paradoxically low answer of growth hormone to stimulation with ornithine].

Authors:  C Lecointre; E Mallet
Journal:  Arch Fr Pediatr       Date:  1990-12

5.  The measurement of growth hormone bioactivity in patient serum using an eluted stain assay.

Authors:  M T Dattani; P C Hindmarsh; P J Pringle; C G Brook; N J Marshall
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

6.  The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males.

Authors:  K Link; R M Blizzard; W S Evans; D L Kaiser; M W Parker; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

7.  Effect of the long-acting somatostatin analogue SMS 201-995 on growth rate and reduction of predicted adult height in ten tall adolescents.

Authors:  M T Tauber; J P Tauber; F Vigoni; A G Harris; P Rochicchioli
Journal:  Acta Paediatr Scand       Date:  1990-02

8.  Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon.

Authors:  N Mauras; R M Blizzard; K Link; M L Johnson; A D Rogol; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

9.  A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

Authors:  T Tanaka; R P Shiu; P W Gout; C T Beer; R L Noble; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

10.  The effect of a continuous infusion of a somatostatin analogue (octreotide) for two years on growth hormone secretion and height prediction in tall children.

Authors:  P C Hindmarsh; P J Pringle; R Stanhope; C G Brook
Journal:  Clin Endocrinol (Oxf)       Date:  1995-05       Impact factor: 3.478

View more
  1 in total

1.  Development of a bioassay system for human growth hormone determination with close correlation to immunoassay.

Authors:  M Maimaiti; Y Tanahashi; Z Mohri; K Fujieda
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.